Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Press Release
Dianthus Therapeutics Early GO Decision in CAPTIVATE CIDP Trial Mar 9, 2026 8:00 AM EDT Webcast Supporting Materials CAPTIVATE Go Decision Interim Responder Analysis 1.2 MB
